Document is current
Any future updates will be listed below
-
Authors
Larrosa-Godall, Mireia
Shackleford, Lewis
Edgington, Matthew P.
Leftwich, Philip T. https://orcid.org/0000-0001-9500-6592
Luk, James C. Y.
Southworth, Joshua
Rosell, Stewart https://orcid.org/0009-0003-2609-9248
Creasey, Jake T. https://orcid.org/0000-0002-1450-298X
Aked, Jack M.
Nevard, Katherine https://orcid.org/0000-0002-1008-6587
Dodds, Alexander
Mckee, Morgan
Adedeji, Eunice
Gonzalez, Estela https://orcid.org/0000-0002-4296-0080
Ang, Joshua X. D. https://orcid.org/0000-0002-4710-8831
Anderson, Michelle A. E. https://orcid.org/0000-0003-1510-2942
Alphey, Luke https://orcid.org/0000-0002-2916-3802
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-008549)
RCUK | Biotechnology and Biological Sciences Research Council (BBS/E/I/00007033, BBS/E/I/00007038, BBS/E/I/00007039)
- License Information
-
More Information
Article History
Received: 25 July 2025
Accepted: 20 April 2026
First Online: 7 May 2026
Competing interests
: L.A. declares the following competing interests: L.A. is an adviser to Synvect Inc and Biocentis Ltd, with equity and/or financial interest in those companies. The other authors declare no competing interests.
